초록접수 현황
| 17F-162 | 포럼 발표 |
Risk Factors of Reintervention after Thoracic Endovascular Aortic Repair for Descending Aortic Pathologies
Young Eun Kim, Jeong-Won Kim, Shin-Ah Son, Jong Tae Lee, Gun Jik Kim
Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University College of Medicine, Daegu, Republic of Korea
Purpose : We determined early and late adverse outcomes including aortic reintervention of thoracic endovascular repair (TEVAR) for thoracic aortic aneurysm and dissection.
Methods : Between October 2009 and July 2016, total 130 patients underwent TEVAR and we excluded 35 traumatic injury patients to evaluate thoracic aortic disease progression after TEVAR. The remaining 95 patients were included in this study, and categorized into 2 groups (Re-intervention group; R group and No-intervention group; N group) according to the need for reintervention. Mean follow-up periods were 21.7 ± 20.7 months.
Results : Overall actuarial survival was 88.1 ± 4 % and 79.2 ± 9 % at 1, and 5 years. Freedom from aortic reintervention after TEVAR was 91.0 ± 5%, 69.4 ± 9%, and 49.5 ± 10 % at 2, 3 and 5 years. Independent risk factors for aortic reintervention were any endoleaks after TEVAR (odds ratio; 67.43, p<0.001). Patients with preoperative hemoptysis had tended to need aortic reintervention (p=0.057). Peripheral vascular disease and preoperative maximum aortic diameter were main determinants of endoleaks (odds ratio; 5.17, p=0.014; odds ratio 1.05, p=0.05; respectively).
Conclusion : Survival after TEVAR for thoracic aortic aneurysm and dissection was satisfactory in most patients for suitable candidates. However, endoleaks or recurrent hemoptysis were the main cause of aortic reintervention after TEVAR.
Methods : Between October 2009 and July 2016, total 130 patients underwent TEVAR and we excluded 35 traumatic injury patients to evaluate thoracic aortic disease progression after TEVAR. The remaining 95 patients were included in this study, and categorized into 2 groups (Re-intervention group; R group and No-intervention group; N group) according to the need for reintervention. Mean follow-up periods were 21.7 ± 20.7 months.
Results : Overall actuarial survival was 88.1 ± 4 % and 79.2 ± 9 % at 1, and 5 years. Freedom from aortic reintervention after TEVAR was 91.0 ± 5%, 69.4 ± 9%, and 49.5 ± 10 % at 2, 3 and 5 years. Independent risk factors for aortic reintervention were any endoleaks after TEVAR (odds ratio; 67.43, p<0.001). Patients with preoperative hemoptysis had tended to need aortic reintervention (p=0.057). Peripheral vascular disease and preoperative maximum aortic diameter were main determinants of endoleaks (odds ratio; 5.17, p=0.014; odds ratio 1.05, p=0.05; respectively).
Conclusion : Survival after TEVAR for thoracic aortic aneurysm and dissection was satisfactory in most patients for suitable candidates. However, endoleaks or recurrent hemoptysis were the main cause of aortic reintervention after TEVAR.
책임저자: Gun Jik Kim
Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University College of Medicine, Daegu, Republic of Korea
발표자: Young Eun Kim, E-mail : darkzephy112@gmail.com